bioRxivMolecular BiologyPreprint
The Universal Receptive System acts as a novel regulator in the production of antimicrobial and anticancer bioactive compounds by white blood cells
Victor TetziD, Kristina M. KardavaiD, Maria F. VecherkovskayaiD, Alireza Khodadadi‐JamayraniD, Aristotelis TsirigosiD, George V. TetziD
Abstract
Despite recent advances, the regulation of anticancer and antimicrobial bioactive compound (AABC) production by leukocytes remains poorly understood. Here, we demonstrate that inactivation of the DNA- and RNA-based Teazeled receptors of the Universal Receptive System in human leukocytes generated so called "Leukocyte-Tells," which showed enhanced AABC production. Comprehensive analysis of the AABCs produced by Leukocyte-Tells based on LC/MS identified 707 unique or differentially produced peptide or non-peptide metabolites. Functional testing demonstrated that many of these metabolites exhibited increased antibacterial, antifungal, and anticancer activities. The AABCs produced by the Leukocyte-Tells were effective against different multidrug-resistant clinical isolates of fungi and gram-positive and gram-negative bacteria (including their biofilms), as well as various cancer cell lines, with >100,000-fold activity than AABCs derived from control leukocytes. Notably, the AABCs produced by the Leukocyte-Tells exhibited greater stability under adverse environmental conditions. Our findings highlight the important role of the Universal Receptive System in regulating AABC production through a process named here as cell genome memory management, offering new insights into immune functions and suggesting potential therapeutic applications. SummaryThe Universal Receptive System acts as a novel regulator of biosynthetic activity in leukocytes. Modulating the leukocyte Universal Receptive System by inactivating Teazeled receptors triggers the production of new compounds not observed in naive cells. We refer to these TezR-modified cells as "Leukocyte-Tells." Leukocytes produce unique metabolites with strong anticancer and antimicrobial activities. Reproducibility in generating leukocytes from the blood of different donors suggests that the observed alterations in cell activity were preprogrammed.
- organism: human
- assay: proteomics
- research focus: cell type annotation
- research focus: differential expression
- research focus: drug response / drug discovery
- approach: experimental assay
- Citations
- 2
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Regulating white blood cell activity through the novel Universal Receptive System
Victor Tetz, Kristina M. Kardava, … George V. Tetz·Scientific ReportsPeer-reviewed·Oct 30, 2025
- Clinically relevant SMAC mimetics do not enhance human T cell proliferation or cytokine production
A. Burton, B. Ligman, … S. E. Murray·bioRxiv·Nov 9, 2021
- Macrophages foster adaptive anti-tumor immunity by ZEB1-dependent cytotoxic T cell chemoattraction
K. Fuchs, I. Armstark, … H. Schuhwerk·bioRxiv·Feb 26, 2024
- ImmTACs overcome cytotoxic T cell suppression
Lan Huynh, Abdullah Aljohani, … Christoph Wülfing·Immunotherapy AdvancesPeer-reviewed·Dec 31, 2025
- Clec7a-mediated regulation of Killer-like Lectin Receptor expression controls T cell immunity
Ivy M. Dambuza, Fabián Salazar, … Gordon D. Brown·bioRxiv·Dec 9, 2025
- Potent antitumor activity of a designed interleukin-21 mimic
Jung-Ho Chun, Birkley S. Lim, … David A. Baker·Science ImmunologyPeer-reviewed·Sep 26, 2025